There are still lots of open positions. Let's find the one that's right for you.
The Director, National Account Management is responsible for developing and implementing an assigned, integrated account strategy for obtaining and maximizing market access and reimbursement to support the launch of Ensitrelvir, a novel 3CL protease inhibitor for the treatment of post exposure prophylaxis (PEP) for SARS-CoV-2 infection in the US and Zatolmilast, an investigational, rare disease treatment for Fragile X Syndrome. This position will also have accountability for critical downstream account access and regional pull through to ensure strategic access goals are met and maximized. Additional accounts to be assigned based on business need. The dynamic nature of Shionogi's portfolio will require this candidate to demonstrate cross functional people leadership success along with deep experience across all key functions of market access to include strategic partnerships with national payers, contracting and GtN management, along with patient services and specialty distribution.